Skip to Main Content

Author Details

Nicola Long
Oregon Health and Science University
2018
15
9
PMIDPaper TitleJournal TitlePublished Year
36441905Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.Blood Adv2023
37698624Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.Blood Cancer Discov2023
37088803NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia.Blood Cancer J2023
37182843CDK12/13 dual inhibitors are potential therapeutics for acute myeloid leukemia.Br J Haematol2023
36976323Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.Mol Cancer Res2023
37361575Immune cell proportions correlate with clinicogenomic features and <i>ex vivo</i> drug responses in acute myeloid leukemia.Front Oncol2023
34482403Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.Blood2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
35078224Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia.Blood Adv2022
32513686Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.Proc Natl Acad Sci U S A2020
32094466Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.Leukemia2020
30425048CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.Blood2019
31366621Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.Blood2019
30559310Two myeloid leukemia cases with rare <i>FLT3</i> fusions.Cold Spring Harb Mol Case Stud2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
  • 1 - 15 of 15

Recommended Authors

Matthieu Duchmann
Assistance Publique-Hopitaux de Paris, Universite de Paris
Career Start Year 2015
Number of shared co-authors 0
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 8
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 2
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 4
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 6
Felicitas Thol
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 8
Courtney D DiNardo
UT MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 16
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 2
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 3
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 14
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Career Start Year 2004
Number of shared co-authors 1
Rhonda E Ries
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 8
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 2
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 1
Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Career Start Year 2000
Number of shared co-authors 7
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 1
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 13
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 29
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 34
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 7
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 6
Kimberly Stegmaier
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 8
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 9
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 26
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 25
Soheil Meshinchi
Fred Hutchinson Cancer Research Centre
Career Start Year 1987
Number of shared co-authors 17
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1983
Number of shared co-authors 7
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 15

Collaborators

Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 14
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 11
Brian J Druker
Oregon Health & Science University
Co-authored papers 10
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 9
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 7
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 7
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 5
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 5
Motomi Mori
St Jude Children's Research Hospital.
Co-authored papers 5
Bill H Chang
Oregon Health and Science University
Co-authored papers 5
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 4
Jennifer N Saultz
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 4
Angela Rofelty
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Beth Wilmot
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers 4
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Ronan Swords
Oregon Health and Science University
Co-authored papers 4
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 4
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 4
Jessica Leonard
Oregon Health & Science University
Co-authored papers 3
Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 3
Rachel Henson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Uma Borate
The Ohio State University
Co-authored papers 3
Amanda d'Almeida
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Elie Traer
Oregon Health & Science University
Co-authored papers 3
David Tyler Sweeney
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Pierrette Lo
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Ted Laderas
Oregon Health & Science University
Co-authored papers 3
Release 1.2